Zusammenfassung
Dünndarmtumoren zählen zu den seltenen Neoplasien, denn sie repräsentieren weniger als 2 % aller gastrointestinalen Tumoren. Dabei treten die Dünndarmtumoren überwiegend im proximalen Dünndarm auf und zeigen häufig ein malignes Wachstum. Die beiden häufigsten Tumorentitäten im Dünndarm sind das Adenokarzinom und die neuroendokrinen Tumoren (NET). Seltenere maligne Tumoren sind die Lymphome und die gastrointestinalen Stromatumoren (GIST). Häufig werden Dünndarmtumoren erst im fortgeschrittenen Stadium diagnostiziert, denn sie verlaufen lange asymptomatisch oder die Symptome sind unspezifisch. Mittels diagnostischer Methoden wie z. B. der Enteroskopie, Kapselendoskopie, aber auch moderner radiologischer bildgebender Verfahren können Dünndarmtumoren allerdings heute oft frühzeitiger diagnostiziert werden. Die Therapie der Dünndarmtumoren variiert erheblich je nach Tumorentität und ist in vielen Fällen interdisziplinär anzugehen. Die Fortschritte im Bereich der Diagnostik und das verbesserte pathogenetische Verständnis der Dünndarmtumoren lassen hoffen, dass zukünftig auch häufiger kurative Therapieansätze gefunden werden können.
Die Originalversion dieses Kapitels wurde revidiert: Der Korrespondenzautor wurde geändert.
Literatur
Agaimy A, Wunsch PH (2009) Lymph node metastasis in gastrointestinal stromal tumours (GIST) occurs preferentially in young patients <= 40 years: an overview based on our case material and the literature. Langenbecks Arch Surg 394:375–381
Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A (2007) Surgical management and outcome in primary adenocarcinoma of the small bowel. Ann Surg Oncol 14:2263–2269
Al-Saleem T, Al-Mondhiry H (2005) Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 105:2274–2280
Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R (2011) Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. Br J Radiol 84(1004):677–690
Arber N, Moshkowitz M (2011) Small bowel polyposis syndromes. Curr Gastroenterol Rep 13:435–441
Beaton C, Davies M, Beynon J (2012) The management of primary small bowel and colon lymphoma – a review. Int J Colorectal Dis 27(5):555–563
Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS (2009) Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 249:63–71
Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Hörsch D, O'Dorisio MS, O'Dorisio TM, Howe JR, Cremonesi M, Kwekkeboom DJ, Zaknun JJ (2013) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40:800–816
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours, Bd. 3 IARC WHO classification of tumours, no 3
Candelaria M, de la Garza J, Duenas-Gonzalez A (2005) A clinical and biological overview of gastrointestinal stromal tumors. Med Oncol 22:1–10
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P, CLARINET Investigators (2014) Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 371:224–233
Chetty R (2008) An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med 132:1285–1289
Coit DG (2001) Cancer of the small intestine. In: DeVita VT Jr (Hrsg) Cancer principles and practice of oncology. 6. Aufl. Cancer Lippincott, Phiadelphia, S 1204–1207
Cronin CG, Scott J, Kambadakone A, Catalano OA, Sahani D, Blake MA, McDermott S (2012) Utility of positron emission tomography/CT in the evaluation of small bowel pathology. Br J Radiol 85:1211–1221
Cross AJ, Leitzmann MF, Subar AF, Thompson FE, Hollenbeck AR, Schatzkin A (2008) A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res 68:9274–9279
d'Amore F, Brincker H, Gronbaek K, Thorling K, Pedersen M, Jensen MK, Andersen E, Pedersen NT, Mortensen LS (1994) Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 12:1673–1684
Daum S, Zeitz M (2007) Dünndarmtumoren. In: Riemann JF, Fischbach W, Galle PR, Mössner J (Hrsg) Gastroenterologie-Das Referenzwerk für Klinik und Praxis. Georg Thieme Verlag, Ludwigshafen/Aschaffenburg/Mainz/Leipzig, S 698–716
Daum S, Weiss D, Hummel M, Ullrich R, Heise W, Stein H, Riecken EO, Foss HD (2001) Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue. Gut 49:804–812
Daum S, Ullrich R, Heise W, Dederke B, Foss HD, Stein H, Thiel E, Zeitz M, Riecken EO (2003) Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol 21:2740–2746
Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ, Connors JM, Rimsza L, Harris NL, Muller-Hermelink K, Rudiger T, Coiffier B, Gascoyne RD, Berger F, Tobinai K, Au WY, Liang R, Montserrat E, Hochberg EP, Pileri S, Federico M, Nathwani B, Armitage JO, Weisenburger DD (2012) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118:148–155
Delle Fave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, Sasano H, Tomassetti P, Salazar R, Ruszniewski P (2012) ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 95:74–87
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG, GRID Study Investigators (2013) Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381(9863):295–302
Edge S, Byrd DR, Compton CC, Fritz AG, Greene F L, Trotti A (2010) AJCC cancer staging manual, Aufl. 7
Ferreri AJ, Zinzani PL, Govi S, Pileri SA (2011) Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 79(1):84–90
Fischbach W (2013) Gastric mucosal-associated lymphoid tissue lymphoma. Gastroenterol Clin North Am 42(2):371–380
Fischbach W, Daum S (2003) Gastrointestinal lymphoma (Review). Dtsch Med Wochenschr 128(37):1899–1901
Gassler N, Knuchel R (2012) Tumors of Vater’s ampulla. Pathologe 33:17–23
Gustafsson BI, Kidd M, Modlin IM (2008) Neuroendocrine tumors of the diffuse neuroendocrine system. Curr Opin Oncol 20:1–12
Hartel M, Wente MN, Sido B, Friess H, Buchler MW (2005) Carcinoid of the ampulla of Vater. J Gastroenterol Hepatol 20:676–681
Hawkes EA, Wotherspoon A, Cunningham D (2012) Diagnosis and management of rare gastrointestinal lymphomas. Leuk Lymphoma 53(12):2341–2350
He Q, Bai Y, Zhi FC, Gong W, Gu HX, Xu ZM, Cai JQ, Pan DS, Jiang B (2013) Double-balloon enteroscopy for mesenchymal tumors of small bowel: nine years’ experience. World J Gastroenterol 19:1820–1826
Heise W (2010) GI-lymphomas in immunosuppressed patients (organ transplantation;HIV). Best Pract Res Clin Gastroenterol 24(1):57–69
Howe JR, Karnell LH, Menck HR, Scott-Conner C (1999) The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–1995. Cancer 86:2693–2706
Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P (2012) Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 13:265–274
Joensuu H, Hohenberger P, Corless CL (2013) Gastrointestinal stromal tumour. Lancet 382:973–983
Karatzas G, Kouraklis G, Karayiannakis A, Patapis P, Givalos N, Kaperonis E (2000) Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen’s disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol 26:428–429
Kim HK, Lo SK (2013) Endoscopic approach to the patient with benign or malignant ampullary lesions. Gastrointest Endosc Clin N Am 23:347–383
Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J, Temmesfeld A, Schmitz R, Rube C, Probst A, Jaenke G, Bodenstein H, Junker A, Pott C, Schultze J, Heinecke A, Parwaresch R, Tiemann M (2001) Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19:3861–3873
König J, Kaiser A, Opfermann P, Manner H, Pohl J, Ell C, May AD (2014) Acute complications after endoscopic resection of duodenal adenomas. Z Gastroenterol 52(2):187–192
Kulichová D, Schauber J, Ruzicka T (2014) Hautmanifestationen bei gastrointestinalen Erkrankungen. Skin changes as signs of gastrointestinal disorders. Dtsch med Wochenschr 139(28/29):1482–1488
Kulke MH, Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340(11):858–868
Lai EC, Lau SH, Lau WY (2012) Current management of gastrointestinal stromal tumors – a comprehensive review. Int J Surg 10:334–340
Lamba G, Gupta R, Lee B, Ambrale S, Liu D (2013) Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol 1:14
Le Cesne A, Blay JY, Reichardt P, Joensuu H (2013) Optimizing tyrosine kinase inhibitor therapy in gastrointestinal stromal tumors: exploring the benefits of continuous kinase suppression. Oncologist 18:1192–1199
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350:239–248
Lembcke B, Weber K, Hohenberger W (2011) Dünndarmtumoren. In: Domschke W, Berger M, Hohenberger W, Meinerth T, Rascher W (Hrsg) Therapiehandbuch. Urban & Fischer, München, S 407–418
Lewis BS, Eisen GM, Friedman S (2005) A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 37:960–965
Lucci-Cordisco E, Risio M, Venesio T, Genuardi M (2013) The growing complexity of the intestinal polyposis syndromes. Am J Med Genet A 161A:2777–2787
Ludwig E, Kurtz RC (2010) Tumors of the small intestine. In: Feldman M, Friedman LS, Brandt LJ (Hrsg) Sleisenger and Fordtran’s gastrointestinal and liver disease. Saunders Elsevier, Philadelphia, S 2145–2155
Malamut G, Chandesris O, Verkarre V, Meresse B, Callens C, Macintyre E, Bouhnik Y, Gornet JM, Allez M, Jian R, Berger A, Châtellier G, Brousse N, Hermine O, Cerf-Bensussan N, Cellier C (2013) Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 45(5):377–384
Marth T, Schmitt-Graff A, Zimmer T, Riecken EO, Wiedenmann B (1996) Gastric hamartoma and thyroid gland carcinoma with follicular and neuroendocrine differentiation in Cowden syndrome. Z Gastroenterol 34:30–35
Miettinen M, Lasota J (2006) Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 130:1466–1478
Miettinen M, El-Rifai W, Sobin LHL, Lasota J (2002) Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 33:478–483
Modlin IM, Shapiro MD, Kidd M (2004) Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol 99:2466–2478
Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD (2005) Current status of gastrointestinal carcinoids. Gastroenterology 128:1717–1751
Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72
Nakamura S, Matsumoto T (2013) Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion 87:182–188
Napoleon B, Gincul R, Ponchon T, Berthiller J, Escourrou J, Canard JM, Boyer J, Barthet M, Ponsot P, Laugier R, Helbert T, Coumaros D, Scoazec JY, Mion F, Saurin JC (2014) Endoscopic papillectomy for early ampullary tumors: long-term results from a large multicenter prospective study. Endoscopy 46:127–134
Nicholl MB, Ahuja V, Conway WC, Vu VD, Sim MS, Singh G (2010) Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol 17:2728–2732
Oberg K (2006) Molecular imaging in diagnosis of neuroendocrine tumours. Lancet Oncol 7:790–792
Overman MJ (2009) Recent advances in the management of adenocarcinoma of the small intestine. Gastrointest Cancer Res 3:90–96
Overman MJ (2013) Rare but real: management of small bowel adenocarcinoma. Am Soc Clin Oncol Educ Book 33:189–193
Overman MJ, Hu CY, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ (2012) A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol 19:1439–1445
Pavel ME, Hainsworth JD, Baudin E, Peeters M, Hörsch D, Winkler RE, Klimovsky J, Lebwohl D, Jehl V, Wolin EM, Oberg K, Van Cutsem E, Yao JC, RADIANT-2 Study Group (2011) Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study. Lancet 378(9808):2005–2012
Rindi G, Kloppel G, Couvelard A, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757–762
Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R, PROMID Study Group (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27:4656–4663
Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (2013) Krebs in Deutschland 2009/2010. 9. Ausgabe, Berlin
Scherübl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G (2011) Management of early gastrointestinal neuroendocrine neoplasms. World J Gastrointest Endosc 3:133–139
Schmoll HJ, Höffken K, Possinger K (2005) Kompendium Internistische Onkologie. Teil 3: Standards in Diagnostik und Therapie. Springer, Heidelberg, S 404–408
Schuchardt C, Kulkarni HR, Prasad V, Zachert C, Müller D, Baum RP (2013) The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC. Recent Results Cancer Res 194:519–536
Serrano C, George S (2014) Recent advances in the treatment of gastrointestinal stromal tumors. Ther Adv Med Oncol 6:115–127
Singeltary B, Ghose A, Sussman J, Choe K, Olowokure O (2014) Durable response with a combination of imatinib and sorafenib in KIT exon 17 mutant gastrointestinal stromal tumor. J Gastrointest Oncol 5:E27–E29
Strosberg J (2012) Neuroendocrine tumours of the small intestine. Best Pract Res Clin Gastroenterol 26:755–773
Terris B, Meddeb M, Marchio A, Danglot G, Flejou JF, Belghiti J, Ruszniewski P, Bernheim A (1998) Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes Chromosomes Cancer 22:50–56
Tonnies H, Toliat MR, Ramel C, Pape UF, Neitzel H, Berger W, Wiedenmann B (2001) Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut 48:536–541
Various authors: ENETS consensus guidelines for the diagnosis and treatment of neuroendocrine tumors (2009–12) http://www.enets.org/guidelines_tnm_classifications.html. Zugegriffen am 03.08.2015
Wardelmann E, Hohenberger P, Reichardt P, Merkelbach-Bruse S, Schildhaus HU, Büttner R (2010) Gastrointestinal stromal tumors of the stomach. Updates and differences compared to other locations. Pathologe 31:195–198
Yamamoto S, Nakase H, Yamashita K, Matsuura M, Takada M, Kawanami C, Chiba T (2010) Gastrointestinal follicular lymphoma: review of the literature. J Gastroenterol 45(4):270–288
Yang F, Jin C, Du Z, Subedi S, Jiang Y, Li J, Di Y, Zhou Z, Tang F, Fu D (2013) Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes. Am J Surg 206:360–367
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after „carcinoid“: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072
Yin L, Chen CQ, Peng CH, Chen GM, Zhou HJ, Han BS, Li HW (2007) Primary small-bowel non-Hodgkin’s lymphoma: a study of clinical features, pathology, management and prognosis. Int Med Res 35(3):406–15. PMID: 17593870
Zentrum für Krebsregisterdaten im Robert Koch-Institut, Prävalenz, www.krebsdaten.de. Zugegriffen am 03.08.2015. (Zeitpunkt der Abfrage 2014)
Zettl A, deLeeuw R, Haralambieva E, Mueller-Hermelink HK (2007) Enteropathy-type T-cell lymphoma. Am J Clin Pathol 127(5):701–706
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Zeuß, D., Marth, T. (2016). Tumoren des Dünndarms. In: Lehnert, H., et al. DGIM Innere Medizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_336-2
Download citation
DOI: https://doi.org/10.1007/978-3-642-54676-1_336-2
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54676-1
eBook Packages: Springer Referenz Medizin
Publish with us
Chapter history
-
Latest
Tumoren des Dünndarms- Published:
- 23 February 2016
DOI: https://doi.org/10.1007/978-3-642-54676-1_336-2
-
Original
Tumoren des Dünndarms- Published:
- 23 May 2015
DOI: https://doi.org/10.1007/978-3-642-54676-1_336-1